SAREPTA THERAPEUTICS (SRPT) Covered Calls

SAREPTA THERAPEUTICS covered calls Sarepta Therapeutics formerly AVI BioPharma remains focused on developing RNA-based therapeutics to improve and save the lives of people affected by serious and life-threatening rare and infectious diseases.

You can sell covered calls on SAREPTA THERAPEUTICS to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for SRPT (prices last updated Fri 4:16 PM ET):

SAREPTA THERAPEUTICS (SRPT) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
119.04 +0.08 116.01 119.99 689K - 7.9B
Covered Calls For SAREPTA THERAPEUTICS (SRPT)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Dec 21 120 8.00 111.99 7.1% 72.0%
Jan 18 120 10.55 109.44 9.6% 54.8%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Sarepta Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the discovery and development of unique RNA-based therapeutics for the treatment of rare and infectious diseases. The company is primarily focused on rapidly advancing the development of its potentially disease modifying duchenne muscular dystrophy drug candidates, including its lead product candidate, eteplirsen. Sarepta Therapeutics was founded on July 22, 1980 and is headquartered in Cambridge, MA.